Headquartered in San Diego, CA, iXCells Biotechnologies is a leading cell biology and cell technology company specializing in preclinical drug discovery solutions with focus on disease relevant cellular models enabling technologies and services to the academic, biotech and pharma communities. iXCells provides high quality primary cells normal and diseased iPS cell lines, iPSC-derived cell products, custom iPSC services, functional bioassay development and execution, among other products and services.
Looking for a particular iXCells Biotechnologies employee's phone or email?
The iXCells Biotechnologies annual revenue was $4 million in 2026.
Nianwei Lin is the Co-Founder, President of iXCells Biotechnologies.
31 people are employed at iXCells Biotechnologies.
iXCells Biotechnologies is based in San Diego, California.
The NAICS codes for iXCells Biotechnologies are [541714, 54171, 54, 541, 5417].
The SIC codes for iXCells Biotechnologies are [873, 87].